Stopping isn't the end of your progress — it's the part that needs a plan. On average about two-thirds of lost weight comes back within a year of stopping, and that's physiology, not willpower. What tilts the odds is the habits you carry off the medication — and staying on a low maintenance dose is a real option too, not a failure.
Wenori's monthly read
Not enough logged yet
Here's how your month really went — once I have a couple of check-ins to read.
Log a check-in in Muscle Preservation (and Side Effects, if you're tracking symptoms) and I'll read weight, waist, muscle, and symptom trend together — the part the scale can't do alone.
The same numbers behind Wenori's read, broken out one at a time.
Vitality
Log a check-in in Muscle Preservation to see this
—
Strength
—
Protein
—
Waist
Three things you can see, tracked in Muscle Preservation. Nothing hidden, no invented unit — this reads real data, not a guess.
What is Vitality, and why does it matter?↓
Vitality is the same weekly scoreboard used across Wenori — strength, protein, and function, the three things sarcopenia research treats as the real early signals of muscle loss. It's tracked once, in Muscle Preservation, and mirrored here so you don't have to log anything twice.
Calibrated to Asian body standards
Most GLP-1 research was built on Western populations. Turn this on and the three numbers below — the ones this system actually watches — adjust for Asian women.
Regain signal
Standard5–10% weight regain before flagging a conversation
Asian-calibratedWaist ≥80cm, or +2cm from your baseline, leads — waist moves before the scale does
Strength cutoff
StandardGeneral resistance-training frequency, no fixed cutoff
Asian-calibratedAWGS 2025, ages 50 to 64: grip under 20 kg, or a five times chair stand of 10 seconds or more, flags low muscle function (65 and over: under 18 kg, or 12 seconds or more)
Bone protection
StandardNot specifically weighted in this transition
Asian-calibratedWeight-bearing work weighted higher — lower average peak bone mass
Off right now — you're seeing the standard thresholds above. Toggle on to switch every read on this page.
This system answers three questions
That's the whole job. Start wherever you are — most women begin at the top.
Did you know
Muscle is one of the most important things to protect as you come off.
It protects your strength, your function and how you feel as weight comes off. That's why this transition reads strength, not just weight, and why a low maintenance dose plus your habits beats white-knuckling it. Clarity reads the whole picture every week, so a bump doesn't become a spiral.
Reviewed by Wenori’s clinical and outcomes research team
Life After GLP-1
A course you buy once and keep. Tracking lives in Clarity, if you want it later.
Your top priority, from your own answers:Log a check-in in Muscle Preservation and I'll read your transition pattern from real data instead of guessing.
Included in the course
The readiness check: what already protects your loss, and what to shore up first
A starting point taper plan to bring to your prescriber, with the honest evidence on tapering
Your Doctor Kit: what to say, what to ask for, and a printable card
What to do if you had to stop fast, and the regain evidence in plain language
Save for Clarity membership
A monthly read of your weight, waist and strength together
Momentum — this transition alongside every other system
Cross-system guidance (Muscle, Side Effects, Plateau)
Includes: the readiness check, taper planner, stop fast guide, evidence and Doctor Kit.
Optional: Clarity membership adds tracking and monthly reads. See Clarity →
Question 1
Am I ready to come off?
Readiness isn't pass/fail. It's a short read on the protective factors that actually tilt the odds — muscle, protein, weight stability, a plan for returning hunger, and how you taper — so you know what to strengthen before, or as, you come off. A couple of minutes, no score to chase.
Why these factorsThey're the ones with the clearest link to holding your loss. The check tells you which are already protecting you, and which are worth a prescriber conversation first.
A gradual step-down tends to give appetite time to adjust rather than changing all at once, which is why many clinicians prefer it to stopping abruptly. There's no single right schedule, and this isn't a prescription — build a starting point here and bring it to your prescriber, who can tailor it to your medication, dose, and how you respond.
The honest versionNo trial has shown that tapering all the way to zero beats simply stopping, when it comes to preventing regain. What the evidence does point to is two things that genuinely protect your loss: staying on a low maintenance dose, and keeping your habits through the transition. So treat this planner as a comfort-and-habits tool — not a regain cure.
Wenori asks
"Tell me why you're thinking about stopping."
Your answer
A couple of practical follow-ups
Which medication are you on
And your current dose
A starting point — not a prescription
Question 3
Am I holding, or regaining?
A bump on the scale doesn't settle it on its own. The trick is reading the trend, not any single week — and looking past the scale to a few signals that move before it does.
What I watch — and why the scale alone misleads
I don't ask you to track six things. I watch a handful together, because the picture across them tells the truth a single weigh-in can't: a steady climb over weeks is the signal; one bump rarely is.
For your body, we lead with waist over weight, read strength against AWGS cutoffs, and give bone extra weight — lower peak bone mass means your weight-bearing work matters more.
The reassuring rule: hunger usually returns within a few weeks of stopping and settles by week 4–5. Protein and strength are the habits doing the most work once the medication isn't. If weight climbs steadily for 3–4 weeks, or hunger feels unmanageable, that's a prescriber conversation — not a willpower problem.
A 60-second protective check
Five quick questions show which factors are already protecting you, and which to shore up first.
Resistance training 2+ times a week?
Consistently hitting your protein target?
Weight stable for 2+ months?
A plan for hunger when it returns?
A low maintenance dose on the table with your prescriber?
Your protective picture
Science & Evidence
What actually happens after you stop
When you've lost weight on a GLP-1, your body doesn't forget how to regain it. My job here isn't to promise "no rebound, ever" — it's to show you what the evidence actually says, and what genuinely moves the odds toward keeping what you earned.
~2/3
of lost weight regained within 1 year in the STEP 1 trial extension, without a structured maintenance plan
~48%
still had a clinically meaningful loss (≥5%) at 1 year post-stop, down from 86% at the end of treatment
~18%
of real-world patients regained all of the weight, or more, within a year
Question 1
How often do women regain?
One year after stopping GLP-1 therapy: who maintains and who regains? Clinical-trial and real-world data tell slightly different stories — worth seeing both.
Clinical trial (STEP 1 extension)~67% of loss regained
Real-world — full regain (all or more)~18%
Real-world — kept ≥5% loss at 1 year~48%
"Most women see some regain. A meaningful share hold on to real loss. A smaller group loses it all. That's exactly why I treat maintenance as its own phase — not just 'hold steady and hope.'"
Where these numbers come from ↓
The STEP 1 extension followed 327 people off semaglutide for a year: they regained a mean 11.6 of the 17.3 percentage points they'd lost, but 48.2% still had ≥5% loss at week 120.1 A separate claims-based study of over 20,000 real-world patients found 17.7% (semaglutide) and 18.7% (liraglutide) regained all of the weight or more within a year of stopping.2 The two numbers aren't contradictory — trial participants had no structured lifestyle support after stopping, while real-world regain varies a lot by how much support and habit-building happened along the way.
Question 2
What changes in your body after stopping?
If hunger comes roaring back or the scale creeps up, that isn't failure — it's physiology pulling on you from three directions at once.
Hunger hormones rebound
The appetite suppression the medication provided fades, and hunger and food noise typically return within a few weeks — usually settling by week 4–5.
Resting energy expenditure drops
A lighter body burns fewer calories at rest, so the same intake that once maintained loss now supports slow regain — unless muscle mass and activity offset it.
Cardiometabolic markers drift back
Blood pressure, lipids, and glucose control tend to move back toward baseline as weight returns — one reason the trend, not any single week, is what matters.
"Nothing is 'wrong' with you when hunger returns or energy dips. Maintenance is about building counter-weight against these forces — not pretending they don't exist."
The evidence behind this ↓
A 2026 systematic review and meta-analysis found cardiometabolic improvements attenuate after cessation, with markers projected to approach baseline roughly 1.4 years post-stop.3 A post-hoc analysis of the SURMOUNT-4 trial found that among people with ≥75% weight regain, cardiometabolic values returned to baseline — but importantly did not exceed it.4
Question 3
Midlife muscle: why 40+ needs a different plan
By 40, you're already losing some muscle every year. Rapid weight loss on top of that — without resistance training and protein — stacks another reason for it to go.
Natural muscle loss, ages 30–60~3–8% per decade
Menopausal transition (lean-mass loss)~0.5%/yr, independent of GLP-1
Lean share of weight lost, drug or placebo (SURMOUNT 1)about 25%
"Protecting muscle isn't a nice-to-have here — it's the difference between lighter and actually resilient. That's why this system talks to your Muscle Preservation numbers, not just the scale."
Muscle mass declines roughly 3–8% per decade from age 30, accelerating after 60.5 During the menopausal transition specifically, lean body mass has been shown to fall about 0.5% (roughly 0.2kg) per year on average, independent of any medication.6 In the SURMOUNT 1 body composition study, about 25% of the weight lost was lean mass, and that share was the same with tirzepatide as with placebo. About a quarter is what weight loss costs by any method. Protein and strength training are what change that share.7
Question 4
What actually helps maintenance most?
For midlife women, "just cardio and eat less" keeps showing up in the rebound group. The women who hold their loss stitch these five habits in together.
Strength training2–3×/week
Protein1.2–1.6 g/kg/day
Movement~150 min/week + daily activity
Monitoringweight + waist, not weight alone
Sleep & stressprotects appetite regulation
"These five, held together, are what tilt you toward the maintenance group. None of them alone does the job — it's the combination that holds."
Question 5
Stopping, tapering, or staying on — what's sensible?
I don't promise you'll never need medication again. What I can do is help you tell normal drift apart from a pattern that genuinely deserves a restart conversation.
1
Taper or continue
2
Maintenance window
3
Threshold check
1
Taper or continue
Discuss a gradual step-down, or staying on a low maintenance dose, with your prescriber. No trial has proven tapering prevents regain better than stopping outright — the honest reason to taper is comfort and habit-building time, not a regain cure.
2
Maintenance window
Watch weight, waist, and Vitality together against a normal-drift band — small fluctuation is expected and not a signal on its own.
3
Threshold check
A steady climb of roughly 5–10% of regained weight, or a multi-week decline across weight, waist, and Vitality together, is what I'd bring to your prescriber — not any single bad week.
Why there's no proven taper protocol ↓
As of the most recent reviews, no randomized controlled trial has directly tested a specific tapering or dose-reduction schedule against abrupt stopping for preventing regain.8 Extended-interval dosing and gradual step-down are described as "pragmatic but unvalidated" options for people facing cost, access, or tolerability barriers — reasonable to discuss, but not a proven regain-prevention strategy on their own.8
Intellectual honesty
What we don't know yet
Where the evidence is still thin
Long-term data specifically in midlife women (40+) after GLP-1 discontinuation are still emerging — most large trials weren't designed to isolate this group.
There's no universally agreed "safe" regain threshold that should trigger a restart; the 5–10% figure above is a reasonable clinical rule of thumb, not a validated cutoff.
No RCT has tested a specific taper schedule against stopping outright for preventing regain.
Some women maintain well on lifestyle changes alone; others need ongoing pharmacotherapy — the research doesn't yet tell us in advance which group someone will be in.
"I won't oversell certainty. Where the research is thin, I say so — and we build your plan around what's actually known, plus your own pattern."
Evidence base: (1) Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553–1564. (2) Epic Research. Many patients maintain weight loss a year after stopping semaglutide and liraglutide. 2024. (3) Systematic review and meta-analysis, weight loss pharmacotherapy cardiometabolic attenuation. 2026. (4) Post-hoc analysis, SURMOUNT-4 trial. (5) Sarcopenia in menopausal women — narrative review. Int J Womens Health. 2022. (6) Menopausal transition and lean body mass — longitudinal cohort data. (7) Look M, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT 1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025;27:2720. (8) Weight regain after GLP-1-based therapy discontinuation: failure, physiology, or follow-up gap. 2026; Weight maintenance after discontinuation of GLP-1 therapies. eClinicalMedicine. 2026. Reviewed for accuracy against current published research.
If you had to stop fast
Had to stop suddenly? Start here
Three of the most common reasons a stop happens fast — each with clear next steps. None of this replaces your prescriber; it's what to do in the meantime.
Cost / insurance crisis
Lost coverage or can't afford it
In the US, contact the manufacturer directly. Novo Nordisk and Eli Lilly both run patient assistance programs. Elsewhere, ask your doctor or pharmacist what support exists where you live.
Ask your prescriber about a dose reduction to stretch supply (lower dose = lower cost = gentler step-down).
If you must come off faster, use the taper planner as a starting point and bring it to your prescriber.
Increase protein and resistance training now — this becomes your regain-protection layer.
If your insurer denied coverage, ask whether you can appeal. The Doctor Kit has a script for requesting the paperwork.
Severe side effects
Side effects forcing you to stop
Contact your prescriber before stopping — many severe side effects are manageable with a dose reduction rather than full discontinuation.
For GI symptoms (constipation, nausea, vomiting), use Wenori SOS for immediate relief while you decide.
Ask about a medication switch — tolerability differs between semaglutide and tirzepatide.
If stopping is final, ask your prescriber for the fastest safe step-down rather than stopping cold.
Rapid regain started
You stopped and weight is coming back
Run the protective check above — it shows which factor to shore up first.
Anchor the basics: protein at every meal, resistance training at least 3×/week.
Track your waist weekly rather than daily weight — daily swings cause panic that makes things worse.
If regain is rapid (more than about 2 kg, or 5 lb, in 4 weeks), contact your prescriber about restarting at a low dose.
Use your weekly check-in to spot the pattern — mood, sleep, and hunger often shift before the scale does.
Important. This is general guidance based on clinical evidence; it doesn't replace medical advice. Always consult your prescribing provider before stopping, reducing, or changing your GLP-1. If you have chest pain, severe vomiting, signs of pancreatitis (severe abdominal pain), or thyroid symptoms — seek emergency care immediately.
Evidence base: Spatz E, Yale School of Medicine — mindset changes in GLP-1 discontinuation (TCTMD, 2026); Truveta Research — GLP-1 discontinuation within one year (ISPOR, 2025); West S, et al. — weight regain after cessation of weight-management medication: systematic review (BMJ, 2026).
Wenori · Doctor Kit
The one page worth bringing to this conversation
Coming off a GLP-1 — or asking to change your plan — goes better with a clear ask. Here’s exactly what to say and what to request, built from why you told us you’re stopping.
01 · What to say
Your opening line
“I want to talk about coming off this medication — I’d like a plan for stepping down, not just stopping.”
Say this verbatim, or use it as your opener. It signals you want a plan, not a rubber stamp.
02 · What to ask for
A written step-down schedule
“Can we put my dose reduction schedule in writing, with target dates?” A plan on paper is easier to follow than a verbal suggestion.
Whether a low maintenance dose fits
“Is staying on a low maintenance dose an option instead of stopping completely?” Often overlooked.
Paperwork for an insurance appeal
“If cost is the issue, can your office help document medical necessity for an appeal?” This applies if you have insurance coverage.
Take to your appointment
Wenori · Transition Off GLP-1
Name
Appointment date
Current dose
What I want to discuss
“I want to talk about coming off this medication — I’d like a plan for stepping down, not just stopping.”
What I’m asking for
A written step-down schedule, with target dates.
Whether a low maintenance dose fits instead of stopping completely.
Paperwork to support an insurance appeal, if cost is the issue and I have coverage.
This is a starting point for a conversation with your prescriber, not a diagnosis or a prescription. Reviewed by Wenori’s clinical and outcomes research team.